EP1.04-20 Phase I Trial of in Situ Vaccination with Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined with Pembrolizumab for Advanced NSCLC

Authors :: Edward B. Garon
Kanwarpal S Kahlon
Linh M. Tran
Zhe Jing
A. Kaul
Jonathan H. Goldman
Scott Genshaft
S. Dubinett
David Elashoff
K. Kostyantyn
Camelia Dumitras
Bin Liu
Gregory A. Fishbein
Ramin Salehi-Rad
Fereidoun Abtin
Robert D. Suh
Raymond J. Lim
Jivianne T. Lee
Aaron Lisberg
S. Ashouri
Source :: Journal of Thoracic Oncology. 14:S978
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
In situ
Vaccination
Oncology
business.industry
Phase (matter)
Cancer research
Medicine
Pembrolizumab
business

Tools